Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci (original) (raw)

References

  1. Broomé, U. & Bergquist, A. Semin. Liver Dis. 26, 31–41 (2006).
    Article Google Scholar
  2. Karlsen, T.H. et al. Gastroenterology 138, 1102–1111 (2010).
    Article Google Scholar
  3. Zhernakova, A., van Diemen, C.C. & Wijmenga, C. Nat. Rev. Genet. 10, 43–55 (2009).
    Article CAS Google Scholar
  4. Bergquist, A. et al. Clin. Gastroenterol. Hepatol. 6, 939–943 (2008).
    Article Google Scholar
  5. Karlsen, T.H., Melum, E. & Franke, A. Hepatology 51, 1833–1842 (2010).
    Article CAS Google Scholar
  6. Price, A.L. et al. Nat. Genet. 38, 904–909 (2006).
    Article CAS Google Scholar
  7. Goyette, P. et al. Mucosal Immunol. 1, 131–138 (2008).
    Article CAS Google Scholar
  8. Strasser, A. Nat. Rev. Immunol. 5, 189–200 (2005).
    Article CAS Google Scholar
  9. Hsu, W. et al. Hepatology 49, 133–140 (2009).
    Article CAS Google Scholar
  10. Hirschfield, G.M. et al. N. Engl. J. Med. 360, 2544–2555 (2009).
    Article CAS Google Scholar

Download references

Acknowledgements

The authors wish to thank all PSC cases and healthy controls for their participation. We also thank K. Cloppenborg-Schmidt, I. Urbach, I. Pauselis, T. Wesse, T. Henke, R. Vogler, B. Stade, T. Vennegerts, P.R. Berg, H.D. Sollid and B. Woldseth for expert technical help. We are grateful to M.K. Viken and M. Nothnagel for helpful discussions. We acknowledge B.A. Lie and the Norwegian Bone Marrow Donor Registry at Oslo University Hospital, Rikshospitalet for contributing the healthy Norwegian control population. We acknowledge F. Braun, W. Kreisel, T. Berg and R. Günther for contributing German PSC cases. We acknowledge A. Strasser for generating and kindly providing the _Bcl2l11_−/− mouse model. We greatly acknowledge A. Kaser for managing the _Bcl2l11_−/− liver histology assessment and for helpful discussions on the functional implications of all findings. The study was supported by The Norwegian PSC research center, the German Federal Ministry of Education and Research (BMBF) through the National Genome Research Network (NGFN), the PopGen biobank, the Integrated Research and Treatment Center–Transplantation (reference number: 01EO0802), the Palumbo Charitable Trust, the Musette and Allen Morgan Jr. Foundation for the Study of PSC, PSC Partners Seeking a Cure and the Mayo Clinic College of Medicine. The project received infrastructure support through the Norwegian Functional Genomics Programme (FUGE) through the 'CIGENE' platform, the Research Computing Services at the University of Oslo and the Deutsche Forschungsgemeinschaft (DFG) excellence cluster 'Inflammation at Interfaces'. The Kooperative Gesundheitsforschung in der Region Augsburg (KORA) research platform was initiated and financed by the Helmholtz Center Munich, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. Part of this work was financed by the German National Genome Research Network (NGFN-2 and NGFNPlus: 01GS0823). This research was also supported within the Munich Center of Health Sciences (MC Health) as part of Ludwig-Maximilians-Universität (LMU) innovativ.

Author information

Author notes

  1. Espen Melum and Andre Franke: These authors contributed equally to this work.
  2. Stefan Schreiber and Tom H Karlsen: These authors jointly directed this work.

Authors and Affiliations

  1. Norwegian PSC Research Center, Clinic for Specialized Medicine and Surgery, Oslo University Hospital, Rikshospitalet, Oslo, Norway
    Espen Melum, Kirsten Muri Boberg, Johannes Roksund Hov, Kristian Holm, Erik Schrumpf & Tom H Karlsen
  2. Research Institute for Internal Medicine, Oslo University Hospital, Rikshospitalet, Oslo, Norway
    Espen Melum & Johannes Roksund Hov
  3. Institute of Clinical Molecular Biology, Christian-Albrechts-University, Kiel, Germany
    Andre Franke, Eva Ellinghaus, Tobias Balschun, David Ellinghaus, Michael Wittig & Stefan Schreiber
  4. 1st Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
    Christoph Schramm & Martina Sterneck
  5. Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany
    Tobias J Weismüller, Jochen Wedemeyer & Michael P Manns
  6. Integrated Research and Treatment Center-Transplantation (IFB-Tx), Hannover Medical School, Hannover, Germany
    Tobias J Weismüller, Jochen Wedemeyer & Michael P Manns
  7. Department of Medicine, University Hospital of Heidelberg, Heidelberg, Germany
    Daniel Nils Gotthardt, Peter Sauer & Adolf Stiehl
  8. Academic Teaching Hospital Feldkirch, Feldkirch, Austria
    Felix A Offner
  9. Division of Gastroenterology and Hepatology, Center for Basic Research in Digestive Diseases, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Brian D Juran & Konstantinos N Lazaridis
  10. Centre for Molecular Biology and Neuroscience (CMBN) and Institute of Medical Microbiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway
    Jon K Laerdahl
  11. Division of Developmental Immunology, Biocenter, Innsbruck Medical University, Innsbruck, Austria
    Verena Labi & Andreas Villunger
  12. Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Einar Björnsson & Björn Lindkvist
  13. Department of Gastroenterology and Hepatology, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands
    Rinse K Weersma
  14. Department of Gastroenterology, University Hospital Gasthuisberg, Leuven, Belgium
    Liesbet Henckaerts & Severine Vermeire
  15. 1st Department of Medicine, University of Mainz, Mainz, Germany
    Andreas Teufel
  16. Department of Medicine 2, Grosshadern, University of Munich, Munich, Germany
    Christian Rust
  17. Department of Gastroenterology and Hepatology, Karolinska University Hospital Huddinge, Stockholm, Sweden
    Annika Bergquist
  18. Division of Biomedical Statistics and Informatics, Mayo Clinic College of Medicine, Rochester, Minnesota, USA
    Euijung Ryu
  19. Hepatobiliary Surgery and Liver Transplantation, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
    Robert J Porte
  20. Institute of Epidemiology, Helmholtz Centre Munich, German Research Center for Environmental Health, Neuherberg, Germany
    Christian Gieger & H-Erich Wichmann
  21. Institute of Medical Informatics, Biometry and Epidemiology, Ludwig-Maximilians-University, Munich, Germany
    H-Erich Wichmann
  22. Klinikum Grosshadern, Munich, Germany
    H-Erich Wichmann
  23. Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
    Pieter Stokkers, Cyriel Y Ponsioen & Ulrich Beuers
  24. Department of Human Genetics, University Hospital of Heidelberg, Heidelberg, Germany
    Heiko Runz
  25. Department of Genetics, University Medical Center Groningen and University of Groningen, Groningen, The Netherlands
    Cisca Wijmenga
  26. Department for General Internal Medicine, Christian-Albrechts-University, Kiel, Germany
    Stefan Schreiber

Authors

  1. Espen Melum
  2. Andre Franke
  3. Christoph Schramm
  4. Tobias J Weismüller
  5. Daniel Nils Gotthardt
  6. Felix A Offner
  7. Brian D Juran
  8. Jon K Laerdahl
  9. Verena Labi
  10. Einar Björnsson
  11. Rinse K Weersma
  12. Liesbet Henckaerts
  13. Andreas Teufel
  14. Christian Rust
  15. Eva Ellinghaus
  16. Tobias Balschun
  17. Kirsten Muri Boberg
  18. David Ellinghaus
  19. Annika Bergquist
  20. Peter Sauer
  21. Euijung Ryu
  22. Johannes Roksund Hov
  23. Jochen Wedemeyer
  24. Björn Lindkvist
  25. Michael Wittig
  26. Robert J Porte
  27. Kristian Holm
  28. Christian Gieger
  29. H-Erich Wichmann
  30. Pieter Stokkers
  31. Cyriel Y Ponsioen
  32. Heiko Runz
  33. Adolf Stiehl
  34. Cisca Wijmenga
  35. Martina Sterneck
  36. Severine Vermeire
  37. Ulrich Beuers
  38. Andreas Villunger
  39. Erik Schrumpf
  40. Konstantinos N Lazaridis
  41. Michael P Manns
  42. Stefan Schreiber
  43. Tom H Karlsen

Contributions

E.M. performed data analysis. A.F. and T.H.K. supervised data analysis and coordinated project contributions. E.E., T.B., D.E., J.R.H. and E.R. helped with data analysis. F.A.O., V.L. and A.V. performed the _Bcl2l11_−/− animal work and liver histology assessments. J.K.L. performed in silico analysis of chromosome 2q13 transcripts. M.W. and K.H. were responsible for in-house conversion and database management of genome-wide association study data. C.S., T.J.W., D.N.G., B.D.J., E.B., R.K.W., L.H., A.T., C.R., K.M.B., C.G., H.-E.W., A.B., P. Sauer, J.W., B.L., R.J.P., P. Stokkers, C.Y.P., H.R., A.S., C.W., M.S., S.V., U.B., E.S., K.N.L., M.P.M. and S.S. provided the case populations and healthy controls. S.S., A.F., T.H.K. and E.M. designed the experiment. E.M. and T.H.K. drafted the manuscript. All authors revised the manuscript and approved of the final version.

Corresponding author

Correspondence toTom H Karlsen.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Rights and permissions

About this article

Cite this article

Melum, E., Franke, A., Schramm, C. et al. Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci.Nat Genet 43, 17–19 (2011). https://doi.org/10.1038/ng.728

Download citation